Bruker Corp. (NASDAQ:BRKR) announced a quarterly dividend on Tuesday, November 15th. Stockholders of record on Monday, December 5th will be paid a dividend of 0.04 per share on Friday, December 23rd. This represents a $0.16 dividend on an annualized basis and a dividend yield of 0.70%. The ex-dividend date is Thursday, December 1st.

Shares of Bruker Corp. (NASDAQ:BRKR) opened at 22.96 on Friday. The company has a market capitalization of $3.68 billion, a price-to-earnings ratio of 25.94 and a beta of 1.04. Bruker Corp. has a 52 week low of $19.58 and a 52 week high of $29.85. The stock has a 50 day moving average of $21.79 and a 200-day moving average of $23.25.

Bruker Corp. (NASDAQ:BRKR) last issued its earnings results on Wednesday, November 2nd. The company reported $0.32 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $0.20 by $0.12. Bruker Corp. had a net margin of 9.02% and a return on equity of 26.05%. The company had revenue of $393.90 million for the quarter, compared to analysts’ expectations of $394.14 million. During the same period in the prior year, the business earned $0.19 EPS. The firm’s quarterly revenue was down .6% on a year-over-year basis. On average, analysts anticipate that Bruker Corp. will post $1.10 EPS for the current year.

Several research analysts have issued reports on BRKR shares. Janney Montgomery Scott upgraded shares of Bruker Corp. from a “neutral” rating to a “buy” rating and set a $28.00 target price on the stock in a report on Wednesday, August 3rd. Leerink Swann started coverage on shares of Bruker Corp. in a report on Thursday, November 10th. They set a “market perform” rating and a $21.00 target price on the stock. Wells Fargo & Co. cut shares of Bruker Corp. from an “outperform” rating to a “market perform” rating in a report on Wednesday, August 3rd. Mizuho dropped their target price on shares of Bruker Corp. from $28.00 to $23.00 and set a “neutral” rating on the stock in a report on Wednesday, August 3rd. Finally, Cantor Fitzgerald reissued a “buy” rating and set a $28.00 price target on shares of Bruker Corp. in a research report on Thursday, November 3rd. Two equities research analysts have rated the stock with a sell rating, ten have given a hold rating, six have assigned a buy rating and one has assigned a strong buy rating to the company’s stock. The company presently has an average rating of “Hold” and an average price target of $25.73.

A number of institutional investors have recently bought and sold shares of the company. The Manufacturers Life Insurance Company acquired a new position in Bruker Corp. during the third quarter worth about $106,000. SG Americas Securities LLC raised its position in Bruker Corp. by 21.2% in the third quarter. SG Americas Securities LLC now owns 7,182 shares of the company’s stock worth $163,000 after buying an additional 1,255 shares in the last quarter. Pacer Advisors Inc. acquired a new position in Bruker Corp. during the second quarter worth about $189,000. AMP Capital Investors Ltd acquired a new position in Bruker Corp. during the third quarter worth about $232,000. Finally, Seven Eight Capital LLC raised its position in Bruker Corp. by 2.6% in the second quarter. Seven Eight Capital LLC now owns 11,700 shares of the company’s stock worth $266,000 after buying an additional 300 shares in the last quarter. 68.90% of the stock is owned by institutional investors.

COPYRIGHT VIOLATION WARNING: “Bruker Corp. (BRKR) to Issue Quarterly Dividend of $0.04 on December 23rd” was first reported by The Cerbat Gem and is owned by of The Cerbat Gem. If you are reading this news story on another site, it was stolen and republished in violation of international copyright and trademark laws. The original version of this news story can be accessed at https://www.thecerbatgem.com/2016/11/26/bruker-corp-brkr-to-issue-quarterly-dividend-of-0-04-on-december-23rd.html.

About Bruker Corp.

Bruker Corporation is a designer and manufacturer of scientific instruments, and analytical and diagnostic solutions. The Company’s operating segments include the Bruker BioSpin Group; the Bruker Chemicals, Applied Markets, Life Science, In-Vitro Diagnostics, Detection (CALID) Group; the Bruker Nano Group, and the Bruker Energy & Supercon Technologies (BEST) Segment.

5 Day Chart for NASDAQ:BRKR

Receive News & Stock Ratings for Bruker Corp. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bruker Corp. and related stocks with our FREE daily email newsletter.